Publication | Open Access
Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol
87
Citations
34
References
2016
Year
NCT02186860.
| Year | Citations | |
|---|---|---|
Page 1
Page 1